Valuation · China A-shares
Chongqing Genrix Biopharmaceutical Co., Ltd. Class A (688443) valuation
As of 2026-11-19, Chongqing Genrix Biopharmaceutical Co., Ltd. Class A trades at ¥23.35, above the highest fair-value bound of its 1, 3 and 5-year windows.
- Price
- ¥23.35
- Day change
- +0.00%
- Market cap
- ¥8.99B
- Valuation
- Above band
- As of
- 2026-11-19
How the valuation band works
Wave Radar estimates a fair-value range from each company's earnings, book value and its own historical P/E and P/B over 1, 3 and 5-year windows. The 1-year window gives the tight range; the widest bounds across all windows give the loose one. "Low" and "High" mean the price has left the tight range; "Below band" and "Above band" mean it has left even the widest one.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.